Lymphogranuloma venereum

Lymphogranuloma Venereum (Chlamydia trachomatis L1-L3)

Medical content reviewed and approved by Dr. GP Yadav, MD, Dermatology Specialist; STI/STD Expert

Definition

Lymphogranuloma venereum (LGV) is a sexually transmitted bacterial infection caused by Chlamydia trachomatis serovars L1, L2, and L3. It features acute lymphadenopathy with bubo formation and can progress to chronic inflammatory sequelae including lymphatic obstruction and tissue scarring.

Symptoms of Lymphogranuloma Venereum

LGV progresses through three clinical stages. The primary stage involves a transient, painless papule, pustule, or ulcer at the inoculation site that often goes unnoticed. The secondary stage (1-6 weeks later) is characterized by painful inguinal lymphadenopathy, typically unilateral, with bubo formation. The 'groove sign' is pathognomonic when lymph nodes above and below the inguinal ligament are enlarged. Systemic symptoms include fever, headache, myalgia, and arthralgia. In MSM, acute proctocolitis with rectal discharge and bleeding is common. The tertiary stage involves chronic inflammatory sequelae with lymphatic obstruction, elephantiasis, and anogenital scarring.

Common Symptoms:

  • Transient, painless genital papule or ulcer (primary stage)
  • Painful inguinal lymphadenopathy (secondary stage - buboes)
  • Fever, chills, myalgia, and arthralgia
  • Proctocolitis in men who have sex with men
  • Anogenital scarring and lymphatic obstruction (tertiary stage)

Clinical Images

Lymphogranuloma venereum inguinal bubo showing painful swollen lymph nodes in groin with characteristic groove sign caused by Chlamydia trachomatis L1-L3

LGV inguinal lymphadenopathy showing a large, painful bubo in the groin region with characteristic erythema and edema of the overlying skin.

Image provided by Dr. GP Yadav

LGV primary genital ulcer showing transient painless papule on penis that precedes inguinal lymphadenopathy in Chlamydia trachomatis infection

Primary LGV lesion presenting as a small, transient, painless papule on the penis that typically heals before the appearance of inguinal lymphadenopathy.

Image provided by Dr. GP Yadav

LGV proctocolitis with rectal mucosal inflammation discharge and bleeding in men who have sex with men infected with Chlamydia trachomatis LGV serovars

LGV proctocolitis demonstrating rectal mucosal inflammation with purulent discharge and mucosal friability, a common presentation in men who have sex with men.

Image provided by Dr. GP Yadav

Transmission of Lymphogranuloma Venereum

LGV is transmitted through direct contact with infected genital lesions, ulcer exudate, or infected lymphatic material during sexual activity. The bacterium enters through micro-abrasions in mucous membranes or skin. LGV has re-emerged as a significant pathogen in men who have sex with men, particularly in HIV-positive individuals, where it commonly presents as proctocolitis. Asymptomatic rectal carriage contributes to ongoing transmission in high-risk networks.

Transmission Methods:

  • Unprotected vaginal intercourse
  • Unprotected anal intercourse
  • Oral-genital contact (less common)
  • Direct contact with infected lymph node material

Incubation Period

Typical period: 3-30 days

The incubation period for the primary lesion of LGV is 3-30 days. The secondary stage with lymphadenopathy typically develops 1-6 weeks after exposure, though the primary lesion may have healed by this time. The variable and often prolonged incubation period between stages can make clinical diagnosis challenging.

Complications of Lymphogranuloma Venereum

Untreated LGV can lead to severe and permanent complications. Chronic lymphatic obstruction causes progressive genital elephantiasis and lymphangitis. Anogenital fistulas and strictures develop from chronic inflammation and fibrosis. Esthiomene is a chronic destructive ulcerative condition of the external genitalia. Rectal strictures can cause obstruction requiring surgical intervention. Systemic complications include reactive arthritis, hepatitis, and rarely, pericarditis. Early diagnosis and treatment are essential to prevent irreversible sequelae.

Possible Complications:

  • Chronic lymphatic obstruction and genital elephantiasis
  • Anogenital fistulas and strictures
  • Esthiomene (chronic ulcerative disease of external genitalia)
  • Rectal strictures and obstruction
  • Systemic dissemination with arthritis and hepatitis

Treatment Options for Lymphogranuloma Venereum

LGV requires extended antibiotic therapy (21 days) due to the intracellular nature of Chlamydia trachomatis serovars L1-L3. Clinical response should be monitored, and treatment continued until all symptoms have resolved. Buboes may require aspiration through healthy adjacent skin to prevent rupture and fistula formation. All sexual partners within the preceding 60 days should be examined and treated. Patients should be tested for HIV, syphilis, and other STIs. Follow-up is recommended until all symptoms have resolved.

Doxycycline 100mg twice daily for 21 days

Doxycycline 100mg orally twice daily for 21 days is the recommended first-line treatment. Extended duration is necessary to eradicate the intracellular pathogen and prevent sequelae.

Azithromycin 1g weekly for 3 weeks

Azithromycin 1g orally once weekly for 3 weeks is an alternative regimen, particularly when doxycycline is contraindicated (pregnancy, children under 8 years).

Erythromycin 500mg four times daily for 21 days

Erythromycin 500mg orally four times daily for 21 days is an alternative for pregnant patients and those unable to tolerate doxycycline or azithromycin.

Prevention of Lymphogranuloma Venereum

Prevention of LGV follows standard STI prevention strategies. Condoms effectively reduce transmission risk. Regular STI screening in high-risk populations, particularly MSM and HIV-positive individuals, enables early detection and treatment. Partner notification and treatment are essential to prevent reinfection and further spread. Health education should focus on recognition of symptoms (particularly lymphadenopathy and proctocolitis) and the importance of seeking prompt medical care.

Prevention Measures:

  • Consistent and correct use of condoms
  • Limiting number of sexual partners
  • Regular STI screening for high-risk individuals
  • Prompt partner notification and treatment
  • Avoiding sexual contact with individuals with genital lesions

Important Disclaimer

  • ⚠️This information is for educational purposes only and should not be used for self-diagnosis.
  • ⚠️For accurate diagnosis and treatment, please consult with a qualified healthcare professional at an accredited medical facility.
  • ⚠️Medical procedures and treatments should only be administered by licensed healthcare providers.
  • ⚠️If you suspect you have an STI, visit STD Nepal clinic for confidential testing and treatment.
WhatsAppBook Now